Pfizer, Eli Lilly, Merck and Other Pharma Stocks Fall as Trump Targets Lower Drug Prices - Barron's
1. Pharmaceutical stocks dropped after Trump's price cut announcement. 2. LLY shares fell 2.25% in premarket trading. 3. Trump proposed a 'most-favored-nation' price policy for drugs. 4. U.S. drug prices may decrease 30% to 80%, impacting revenue. 5. Overall market rallied despite healthcare stock declines.